Literature DB >> 1313249

Facial paralysis due to benign parotid tumors.

N H Blevins1, R K Jackler, M J Kaplan, R Boles.   

Abstract

On rare occasions, facial paralysis associated with a parotid tumor need not denote malignancy. We present two cases in which, contrary to appropriate conventional wisdom, facial paralysis resulted from benign mixed tumors. Each patient presented over 8 years following primary surgical excision. In neither patient was a mass palpable, and facial paralysis was the sole sign of recurrent disease. Each patient had been followed up for several months with a presumptive diagnosis of Bell's palsy prior to discovery of recurrent tumor by radiologic imaging. In each case, at operation the tumor was found to infiltrate the temporal bone via the stylomastoid foramen. Facial paralysis presumably resulted from extrinsic compression of the facial nerve. These two cases add to the few previous reports of facial paralysis due to benign parotid gland tumors.

Entities:  

Mesh:

Year:  1992        PMID: 1313249     DOI: 10.1001/archotol.1992.01880040093015

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  4 in total

1.  Benign parotid mass and facial palsy: systematic review.

Authors:  K E Stewart; R Bannon; M Bannister
Journal:  Ann R Coll Surg Engl       Date:  2020-09-24       Impact factor: 1.891

2.  Intermittent facial spasms as the presenting sign of a recurrent pleomorphic adenoma.

Authors:  Rosalie A Machado; Sami P Moubayed; Azita Khorsandi; Juan C Hernandez-Prera; Mark L Urken
Journal:  World J Clin Oncol       Date:  2017-02-10

3.  Facial Nerve Paralysis due to a Pleomorphic Adenoma with the Imaging Characteristics of a Facial Nerve Schwannoma.

Authors:  Marc-Elie Nader; Diana Bell; Erich M Sturgis; Lawrence E Ginsberg; Paul W Gidley
Journal:  J Neurol Surg Rep       Date:  2014-04-17

4.  Oncocytoma of the Parotid Gland with Facial Nerve Paralysis.

Authors:  Seijiro Hamada; Keishi Fujiwara; Hiromitsu Hatakeyama; Akihiro Homma
Journal:  Case Rep Otolaryngol       Date:  2018-06-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.